The Most Desired Values of High Density Lipoproteins in the Metabolic Syndrome
- 1 June 2020
- journal article
- research article
- Published by Medi + World International in World Family Medicine Journal/Middle East Journal of Family Medicine
- Vol. 18 (6), 33-39
- https://doi.org/10.5742/mewfm.2020.93818
Abstract
High Density Lipoproteins | Low Density Lipoproteins | Triglycerides | Acute Phase Proteins | Body Mass Index | Smoking | Metabolic SyndromeKeywords
This publication has 24 references indexed in Scilit:
- Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicineProteomics – Clinical Applications, 2016
- HDL in Infectious Diseases and SepsisPublished by Springer Science and Business Media LLC ,2014
- Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patientsBMJ, 2014
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Complexities of plasma apolipoprotein C-III metabolismJournal of Lipid Research, 2011
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studiesThe Lancet, 2010
- Metformin and Parameters of Physical HealthInternal Medicine, 2008
- Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcomeFree Radical Research, 2007
- The “Good Cholesterol”Journal of the American College of Cardiology, 2005
- European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurementJournal of Hypertension, 2003